financetom
Business
financetom
/
Business
/
Cogent Communications Holdings Insider Sold Shares Worth $1,173,318, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cogent Communications Holdings Insider Sold Shares Worth $1,173,318, According to a Recent SEC Filing
May 27, 2025 1:37 PM

04:21 PM EDT, 05/27/2025 (MT Newswires) -- Dave Schaeffer, Director, Chairman, CEO, and President, on May 23, 2025, sold 25,000 shares in Cogent Communications Holdings ( CCOI ) for $1,173,318. Following the Form 4 filing with the SEC, Schaeffer has control over a total of 4,151,721 common shares of the company, with 4,151,721 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1158324/000141588925014604/xslF345X05/form4-05272025_080539.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Birkenstock's Q2 Revenue Rises 22%, Beats Expectations With Strong Global Demand: Details
Birkenstock's Q2 Revenue Rises 22%, Beats Expectations With Strong Global Demand: Details
May 30, 2024
Birkenstock Holding plc ( BIRK ) shares are trading higher after the company reported the second quarter fiscal 2024 results. Revenue grew 22% on a reported basis (+23% Y/Y on a constant currency basis) EUR 481 million, led by continued strong consumer demand for its products across all segments, channels, and categories. Adjusted EPS stood at EUR 0.41, flat Y/Y, in...
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
May 30, 2024
09:07 AM EDT, 05/30/2024 (MT Newswires) -- Willow Biosciences ( CANSF ) , a biotechnology company, said Thursday that it signed a multi-product development and licensing partnership with Laurus Labs, a research-driven pharmaceutical and biotechnology company. Under the partnership, Willow will deliver biobased processes for high-value Active Pharmaceutical Ingredients with existing markets, including Willow's BioOxi-based corticosteroid processes, for large-scale manufacturing,...
BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer
BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer
May 30, 2024
09:08 AM EDT, 05/30/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) initiated a first-in-human, Phase 1/2 study evaluating safety and efficacy of Bria-OTS, BriaCell's personalized off-the-shelf next generation immunotherapy, as monotherapy and in combination with a PD-1 inhibitor, tislelizumab, in advanced metastatic breast cancer. Briacell says the off-the-shelf nature of the treatment will allow patients to be treated rapidly....
C3.ai Stock Is Rising Thursday: What's Going On?
C3.ai Stock Is Rising Thursday: What's Going On?
May 30, 2024
C3.Ai Inc ( AI ) shares are trading higher Thursday after the company reported better-than-expected financial results for its fiscal fourth quarter. What Happened: C3.ai ( AI ) reported fourth-quarter revenue of $86 million, beating analyst estimates of $84.395 million. The enterprise AI software company reported an adjusted loss of 11 cents per share, beating estimates for a loss of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved